Preview

Cancer Urology

Advanced search

Kidney re-resections 5 years after extracorporeal resections

https://doi.org/10.17650/1726-9776-2014-10-4-23-26

Abstract

The possible way to solve the problems associated with a risk from non-radical tumor removal, inadequate repair and a drastic reduction in renal function after long-term technically challenging in situ parenchymal ischemia resections is a surgical intervention into the kidney removed from the body, which has been preserved by the procedure developed for donor organs, during hypothermia that promotes a severe decrease in the intensity of oxygen-dependent processes in the renal epitheliocytes, followed by autografting of the resected kidney. The main advantages of the extracorporeal technique are the excellent ex corpora visualization of renal structures and the unrestricted time of surgery with good anti-ischemic protection. Resurgery after routine (in situ) resections yields good long-term oncological and functional results in correctly selected patients. Repeated tumor removal after extracorporeal kidney resection is a technically challenging surgical intervention undescribed in the literature.

About the Authors

O. R. Nazarova
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences; 24, Kashirskoe Sosshe, Moscow 115230, Russia
Russian Federation


D. V. Perlin
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences; 24, Kashirskoe Sosshe, Moscow 115230, Russia
Russian Federation


M. I. Volkova
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences; 24, Kashirskoe Sosshe, Moscow 115230, Russia
Russian Federation


L. L. Gurariy
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences; 24, Kashirskoe Sosshe, Moscow 115230, Russia
Russian Federation


V. B. Matveev
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences; 24, Kashirskoe Sosshe, Moscow 115230, Russia
Russian Federation


References

1. Бикбов Б.Т., Томилина Н.А. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998–2009 гг. (Отчет по данным Российского регистра заместительной почечной терапии). Нефрология и диализ 2011;13(3):152–250.

2. Матвеев В.Б., Матвеев Б.П., Волкова М.И. и др. Роль органосохраняющего лечения рака почки на современном этапе. Онкоурология 2007;2:5–11.

3. MacLennan S., Imamura M., Lapitan M.C. et al. Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol 2012;61(5): 972–93.

4. Roos F.C., Pahernik S., Brenner W., Thüroff J.W. Imperative and elective indications for nephron-sparing surgery for renal tumors: long-term oncological follow-up. Actuelle Urol 2010;41(Suppl 1):70–6.


Review

For citations:


Nazarova O.R., Perlin D.V., Volkova M.I., Gurariy L.L., Matveev V.B. Kidney re-resections 5 years after extracorporeal resections. Cancer Urology. 2014;10(4):23-26. (In Russ.) https://doi.org/10.17650/1726-9776-2014-10-4-23-26

Views: 797


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)
X